(Q43038765)

12 November 2017

Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

3

Priyanka Bandara

1 reference

12 November 2017

Ian Homer Y Cua

1

1 reference

12 November 2017

Jason M Hui

2

1 reference

12 November 2017

James G Kench

4

1 reference

12 November 2017

Geoffrey C Farrell

5

1 reference

12 November 2017

Geoffrey W McCaughan

6

1 reference

12 November 2017

Jacob George

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

12 November 2017

1 reference

12 November 2017

46

1 reference

12 November 2017

1

1 reference

12 November 2017

66-73

1 reference

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes

12 November 2017

1 reference

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

21 January 2018

1 reference

7 January 2021

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Steatosis affects chronic hepatitis C progression in a genotype specific way

1 reference

7 January 2021

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

1 reference

7 January 2021

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

1 reference

7 January 2021

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

1 reference

7 January 2021

Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

1 reference

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

7 January 2021

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

1 reference

7 January 2021

Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

1 reference

7 January 2021

Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy

1 reference

7 January 2021

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

1 reference

7 January 2021

Adipocytokines and insulin resistance

1 reference

7 January 2021

Review article: adipocytokines and insulin resistance

1 reference

7 January 2021

Insulin resistance: a metabolic pathway to chronic liver disease

1 reference

7 January 2021

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

1 reference

7 January 2021

Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin

1 reference

7 January 2021

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

7 January 2021

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

1 reference

7 January 2021

Immune responses and immunity in hepatitis C virus infection

1 reference

7 January 2021

Hepatitis C pathogenesis: Mechanisms of viral clearance and liver injury

1 reference

7 January 2021

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

1 reference

7 January 2021

The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C

1 reference

7 January 2021

Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis

1 reference

7 January 2021

Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection

1 reference

7 January 2021

Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity

1 reference

7 January 2021

Enhanced expression of interleukin-6 in chronic hepatitis C

1 reference

7 January 2021

Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus

1 reference

7 January 2021

Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Correlation of serum leptin levels with insulin sensitivity in patients with chronic hepatitis-C infection.

1 reference

7 January 2021

Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients

1 reference

7 January 2021

Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy

1 reference

7 January 2021

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.

1 reference

7 January 2021

Adiponectin and its receptors in patients with chronic hepatitis C.

1 reference

7 January 2021

Increased resistin gene and protein expression in human abdominal adipose tissue.

1 reference

7 January 2021

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

1 reference

7 January 2021

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

1 reference

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

7 January 2021

Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients

1 reference

7 January 2021

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

1 reference

7 January 2021

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

1 reference

7 January 2021

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21703

1 reference

12 November 2017

1 reference